These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 17381382)
1. Safety of newer antidepressants in pregnancy. Way CM Pharmacotherapy; 2007 Apr; 27(4):546-52. PubMed ID: 17381382 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]. Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456 [TBL] [Abstract][Full Text] [Related]
3. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review. Tuccori M; Testi A; Antonioli L; Fornai M; Montagnani S; Ghisu N; Colucci R; Corona T; Blandizzi C; Del Tacca M Clin Ther; 2009 Jun; 31 Pt 1():1426-53. PubMed ID: 19698902 [TBL] [Abstract][Full Text] [Related]
4. Antidepressants in pregnancy: a systematic review. Udechuku A; Nguyen T; Hill R; Szego K Aust N Z J Psychiatry; 2010 Nov; 44(11):978-96. PubMed ID: 21034181 [TBL] [Abstract][Full Text] [Related]
5. Antidepressant use in pregnancy and the risk of cardiac defects. Huybrechts KF; Palmsten K; Avorn J; Cohen LS; Holmes LB; Franklin JM; Mogun H; Levin R; Kowal M; Setoguchi S; Hernández-Díaz S N Engl J Med; 2014 Jun; 370(25):2397-407. PubMed ID: 24941178 [TBL] [Abstract][Full Text] [Related]
6. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis. Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040 [TBL] [Abstract][Full Text] [Related]
7. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data. Singal D; Brownell M; Chateau D; Ruth C; Katz LY BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401 [TBL] [Abstract][Full Text] [Related]
11. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation. Sie SD; Wennink JM; van Driel JJ; te Winkel AG; Boer K; Casteelen G; van Weissenbruch MM Arch Dis Child Fetal Neonatal Ed; 2012 Nov; 97(6):F472-6. PubMed ID: 23080479 [TBL] [Abstract][Full Text] [Related]
12. Use of antidepressants during pregnancy and the risk of spontaneous abortion. Nakhai-Pour HR; Broy P; Bérard A CMAJ; 2010 Jul; 182(10):1031-7. PubMed ID: 20513781 [TBL] [Abstract][Full Text] [Related]
13. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. Grigoriadis S; Vonderporten EH; Mamisashvili L; Tomlinson G; Dennis CL; Koren G; Steiner M; Mousmanis P; Cheung A; Ross LE BMJ; 2014 Jan; 348():f6932. PubMed ID: 24429387 [TBL] [Abstract][Full Text] [Related]
14. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. Bérard A; Zhao JP; Sheehy O BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367 [TBL] [Abstract][Full Text] [Related]
15. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202 [TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis. Eke AC; Saccone G; Berghella V BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775 [TBL] [Abstract][Full Text] [Related]
17. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring. Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704 [TBL] [Abstract][Full Text] [Related]
18. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923 [TBL] [Abstract][Full Text] [Related]
19. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark. Jordan S; Morris JK; Davies GI; Tucker D; Thayer DS; Luteijn JM; Morgan M; Garne E; Hansen AV; Klungsøyr K; Engeland A; Boyle B; Dolk H PLoS One; 2016; 11(12):e0165122. PubMed ID: 27906972 [TBL] [Abstract][Full Text] [Related]
20. [Current evaluation of teratogenic and fetotoxic effects of psychotropic drugs]. Watanabe O Seishin Shinkeigaku Zasshi; 2014; 116(12):996-1004. PubMed ID: 25823351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]